Crohn’s disease and ulcerative colitis are inflammatory bowel diseases, but Crohn’s can affect different parts of the digestive tract while ulcerative colitis affects the colon. Their symptoms often overlap, so clinicians use testing to identify the condition and guide treatment. 1 2
Not sure where to start? Take the 3-min clinical quiz.
See if you qualify →How are Crohn’s disease and ulcerative colitis different?
Crohn’s disease and ulcerative colitis are both inflammatory bowel diseases (IBD), meaning the immune system drives ongoing inflammation in the digestive tract. The main difference is where inflammation occurs and how it spreads. 1 2
| Feature | Crohn’s disease | Ulcerative colitis |
|---|---|---|
| Where it occurs | Any part of the digestive tract, most often the small intestine or colon | The colon and rectum only |
| Pattern of inflammation | Can occur in patches, with healthy tissue between inflamed areas | Usually starts in the rectum and extends continuously through part or all of the colon |
| Depth of inflammation | Can affect the full thickness of the bowel wall | Usually affects the inner lining of the colon |
| Common complications | Narrowing, fistulas, abscesses, and nutrition problems | Severe colon inflammation, bleeding, and a higher long-term colorectal cancer risk with extensive disease |
| Role of surgery | May manage a complication but does not guarantee Crohn’s will not return | Removing the colon removes colitis from the colon |
These patterns help clinicians, but they are not perfect. Some people initially have inflammation that cannot be clearly classified as Crohn’s disease or ulcerative colitis. 1 2
Where in the digestive tract can each condition cause inflammation?
Crohn’s disease can involve the digestive tract from mouth to anus, though the end of the small intestine and the colon are common sites. Ulcerative colitis is limited to the colon and rectum. 1 2
Crohn’s inflammation can extend deeper into the bowel wall. That deeper pattern can lead to tunnels between organs or skin, called fistulas, or narrowed bowel segments. Ulcerative colitis usually affects the surface lining of the colon. 1 2
Location matters because it affects symptoms, nutrition concerns, imaging choices, and surgery planning. For a fuller overview of the condition, see our guide to what Crohn’s disease is.
What symptoms can Crohn’s disease and ulcerative colitis cause?
Both Crohn’s disease and ulcerative colitis can cause diarrhea, belly pain, fatigue, and weight loss. Rectal bleeding and urgency are especially common when ulcerative colitis involves the rectum. 1 2
- Crohn’s disease may cause diarrhea, cramping, fever, poor appetite, weight loss, mouth sores, or pain around the anus. 1
- Ulcerative colitis may cause bloody diarrhea, urgent bowel movements, mucus in stool, abdominal discomfort, and fatigue. 2
- Either condition can cause symptoms outside the gut, including joint pain, eye inflammation, skin changes, or liver and bile-duct disease. 1 2
Symptoms alone cannot diagnose IBD. Infections, celiac disease, medication effects, and irritable bowel syndrome symptoms can overlap with some digestive complaints. IBS does not cause the bowel inflammation seen in IBD. 3
Why can Crohn’s disease and ulcerative colitis be hard to tell apart?
Crohn’s disease and ulcerative colitis can be hard to distinguish because both can cause diarrhea, bleeding, pain, and inflammation in the colon. A diagnosis often requires more than one test, rather than a single blood test or symptom checklist. 1 2
Clinicians consider the inflammation pattern, biopsy findings, small-bowel imaging, family history, medicines, infection testing, and symptoms over time. A small group of people are diagnosed with IBD-unclassified when available evidence does not yet support one subtype. 4
How do clinicians diagnose Crohn’s disease versus ulcerative colitis?
Clinicians diagnose Crohn’s disease or ulcerative colitis by combining symptoms with blood tests, stool tests, endoscopy, biopsies, and imaging when needed. Colonoscopy with tissue samples is central to diagnosis because it shows where inflammation is present and what it looks like under a microscope. 1 2
Medical history, blood testing, and stool testing
Blood tests can identify anemia, inflammation, or nutrition concerns. Stool testing can look for infections and measure markers such as fecal calprotectin, which may help show intestinal inflammation but cannot diagnose IBD on its own. 1 2
Endoscopy, biopsies, and medical imaging
During endoscopy, a clinician examines the rectum and colon and takes biopsies. CT enterography or MRI enterography can evaluate areas beyond the reach of a colonoscope, including the small intestine and complications such as strictures or fistulas. 1 4
If you have ongoing bowel changes, intestinal inflammation symptoms and diagnosis can help you prepare for a clinical visit. It cannot replace an exam or testing.
How do treatment approaches differ for Crohn’s disease and ulcerative colitis?
Crohn’s disease and ulcerative colitis treatment aims to control inflammation, reduce symptoms, prevent complications, and support nutrition. The best treatment depends on disease location, severity, prior treatment, and complications, not just the disease name. 1 2
Treatment can include anti-inflammatory medicines, immune-targeting medicines, nutrition support, iron or vitamin replacement when needed, and surgery. Prescription choices have meaningful risks, including infection risk with immune-suppressing medicines, so a gastroenterologist weighs benefits and harms for the individual. 1 2
Biologic medicines and other advanced therapies
Biologic medicines target parts of the immune system. Infliximab (Remicade) is an anti-tumor necrosis factor biologic studied for inducing and maintaining improvement in moderate-to-severe ulcerative colitis; serious infections and infusion reactions are among the risks clinicians monitor. 5
Vedolizumab (Entyvio) is an anti-integrin biologic that acts mainly in the gut. Long-term clinical-study data evaluated its safety in people with IBD, but no immune-targeting treatment is risk-free and ongoing monitoring remains important. 6
Guselkumab (Tremfya) is an interleukin-23p19 monoclonal antibody. Phase 3 trials studied guselkumab in adults with moderately to severely active ulcerative colitis and Crohn’s disease; infections and injection-related effects remain part of treatment safety discussions. 7 8
Route matters for some medicines. Randomized phase 3 trials evaluated subcutaneous infliximab as maintenance therapy in IBD, but evidence from one medicine or IBD subtype does not automatically apply to another medicine, route, or condition. 9
When surgery may be considered
Surgery may be considered for severe disease that does not respond to medicine, major bleeding, bowel blockage, fistulas, abscesses, dysplasia, or cancer concerns. Removing the colon can remove ulcerative colitis from the colon, while Crohn’s disease can recur in another part of the digestive tract after surgery. 1 2
For a more detailed look at care options, read our guide to treatment for Crohn’s disease and inflammatory bowel disease treatment.
What can people eat with Crohn’s disease or ulcerative colitis?
There is no single diet that works for every person with Crohn’s disease or ulcerative colitis. Food plans should protect nutrition while fitting your symptoms, disease activity, and bowel anatomy, especially after surgery or during a flare. 1 2
Some people tolerate lower-fiber foods better during a flare or with a narrowing. Others need help meeting calorie, protein, iron, vitamin B12, vitamin D, or calcium needs. A gastroenterologist and IBD-trained dietitian can tailor changes safely. 1
What Mediterranean-style eating research can and cannot show
A 2021 study examined the broader effects of a Mediterranean diet among people with IBD. It supports studying food quality in IBD care, but it does not show that one eating pattern replaces prescription treatment or works the same way for every person. 10
A Mediterranean-style pattern usually emphasizes vegetables, fruit, legumes, whole grains, olive oil, fish, and nuts. During active symptoms, those foods may need adjustment for tolerance. Our Mediterranean diet guide explains the pattern, though fatty-liver guidance is not an IBD treatment plan.
Can a person have both Crohn’s disease and ulcerative colitis?
A person is usually diagnosed with Crohn’s disease or ulcerative colitis, not both. When findings are unclear, clinicians may use IBD-unclassified rather than force an early label. Later testing or disease patterns can sometimes clarify the diagnosis. 4
A changing diagnosis does not mean someone did anything wrong. It reflects how similar these conditions can look early on and why follow-up with an IBD care team matters. 4
When should symptoms prompt urgent medical care?
Seek urgent medical evaluation for severe abdominal pain, persistent vomiting, dehydration, high fever, significant rectal bleeding, fainting, or possible bowel obstruction. These symptoms can signal a serious IBD complication or another urgent digestive condition. 1 2
- Contact a clinician promptly for worsening diarrhea, new bleeding, unexplained weight loss, fever, or symptoms that disrupt eating and drinking. 1 2
- Seek emergency care for severe or rapidly worsening pain, a swollen abdomen, inability to pass stool or gas, repeated vomiting, confusion, or fainting. 1
- Do not start, stop, or change prescription IBD treatment based on general online information. Treatment selection needs a qualified clinician, often a gastroenterologist. 1 2
What else do people ask about Crohn’s disease and ulcerative colitis?
Ulcerative colitis does not simply turn into Crohn’s disease. Sometimes early test results are unclear, and later findings lead clinicians to revise the diagnosis. 4
No. Chia’s current catalog does not list a treatment for Crohn’s disease or ulcerative colitis. BPC-157 is not FDA-approved and should not be viewed as an established treatment for either condition.
References
- 1.National Institute of Diabetes and Digestive and Kidney Diseases. Crohn’s Disease. 2023.
- 2.National Institute of Diabetes and Digestive and Kidney Diseases. Ulcerative Colitis. 2023.
- 3.National Institute of Diabetes and Digestive and Kidney Diseases. Symptoms & Causes of Irritable Bowel Syndrome. 2023.
- 4.Torres J, Bonovas S, Doherty G, et al. ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment. Journal of Crohn's and Colitis. 2020.
- 5.Rutgeerts P, Sandborn WJ, Feagan BG, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. New England Journal of Medicine. 2005.
- 6.Loftus EV Jr, Feagan BG, Panaccione R, et al. Long-term safety of vedolizumab for inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 2020.
- 7.Rubin DT, Allegretti JR, Panés J, et al. Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies. Lancet. 2025.
- 8.Hart A, Panaccione R, Steinwurz F, et al. Efficacy and Safety of Guselkumab Subcutaneous Induction and Maintenance in Participants With Moderately to Severely Active Crohn's Disease: Results From the Phase 3 GRAVITI Study. Gastroenterology. 2025.
- 9.Hanauer SB, Sands BE, Schreiber S, et al. Subcutaneous Infliximab (CT-P13 SC) as Maintenance Therapy for Inflammatory Bowel Disease: Two Randomized Phase 3 Trials (LIBERTY). Gastroenterology. 2024.
- 10.Chicco F, Magrì S, Cingolani A, et al. Multidimensional Impact of Mediterranean Diet on IBD Patients. Inflammatory Bowel Diseases. 2021.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
Find what fits your body and your goals.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.



